1
Clinical Trials associated with iPSC-Derived Islet Cells(Hangzhou Ruipu Chenchuang Technology) / Not yet recruitingNot ApplicableIIT A Single-Arm, Open-Label Clinical Study of iPSC-Derived Islet Cells for the Treatment of Diabetes Mellitus
This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus.
100 Clinical Results associated with iPSC-Derived Islet Cells(Hangzhou Ruipu Chenchuang Technology)
100 Translational Medicine associated with iPSC-Derived Islet Cells(Hangzhou Ruipu Chenchuang Technology)
100 Patents (Medical) associated with iPSC-Derived Islet Cells(Hangzhou Ruipu Chenchuang Technology)
100 Deals associated with iPSC-Derived Islet Cells(Hangzhou Ruipu Chenchuang Technology)